Glucose restriction in Saccharomyces cerevisiae modulates the phosphorylation pattern of the 20S proteasome and increases its activity (2023)
- Authors:
- USP affiliated authors: OLIVEIRA, CRISTIANO LUIS PINTO DE - IF ; RONSEIN, GRAZIELLA ELIZA - IQ
- Unidades: IF; IQ
- DOI: https://dx.doi.org/10.1038/s41598-023-46614-x
- Subjects: GLICOSE; SACCHAROMYCES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Scientific Reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v. 13, p. 1-14 art. 19383, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BICEV, Renata N et al. Glucose restriction in Saccharomyces cerevisiae modulates the phosphorylation pattern of the 20S proteasome and increases its activity. Scientific Reports, v. 13, p. 1-14 art. 19383, 2023Tradução . . Disponível em: https://dx.doi.org/10.1038/s41598-023-46614-x. Acesso em: 30 abr. 2024. -
APA
Bicev, R. N., Degenhardt, M. F. de S., Oliveira, C. L. P. de, Silva, E. R. da, Degrouard, J., Tresset, G., et al. (2023). Glucose restriction in Saccharomyces cerevisiae modulates the phosphorylation pattern of the 20S proteasome and increases its activity. Scientific Reports, 13, 1-14 art. 19383. doi:https://dx.doi.org/10.1038/s41598-023-46614-x -
NLM
Bicev RN, Degenhardt MF de S, Oliveira CLP de, Silva ER da, Degrouard J, Tresset G, Ronsein GE, Demasi M, Cunha FM da. Glucose restriction in Saccharomyces cerevisiae modulates the phosphorylation pattern of the 20S proteasome and increases its activity [Internet]. Scientific Reports. 2023 ; 13 1-14 art. 19383.[citado 2024 abr. 30 ] Available from: https://dx.doi.org/10.1038/s41598-023-46614-x -
Vancouver
Bicev RN, Degenhardt MF de S, Oliveira CLP de, Silva ER da, Degrouard J, Tresset G, Ronsein GE, Demasi M, Cunha FM da. Glucose restriction in Saccharomyces cerevisiae modulates the phosphorylation pattern of the 20S proteasome and increases its activity [Internet]. Scientific Reports. 2023 ; 13 1-14 art. 19383.[citado 2024 abr. 30 ] Available from: https://dx.doi.org/10.1038/s41598-023-46614-x - Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
- Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
- Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles
- Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
- Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects
- Time to ditch HOL-C as a measure of PINION HOL function?
- Inflammation, remodeling, and other factors affecting HDL cholesterol efflux
- Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients
- Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration
- Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone
Informações sobre o DOI: https://dx.doi.org/10.1038/s41598-023-46614-x (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | s41598-023-46614-x.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
